Center for Substance Abuse Prevention; Notice of Meeting, 3347 [2017-00396]

Download as PDF sradovich on DSK3GMQ082PROD with NOTICES Federal Register / Vol. 82, No. 7 / Wednesday, January 11, 2017 / Notices Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR 16– 278: Stimulating Innovations in Intervention Research for Cancer Prevention and Control. Date: February 7, 2017. Time: 10:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: The Westgate Hotel, 1055 Second Avenue, San Diego, CA 92101. Contact Person: Lee S Mann, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3186, MSC 7848, Bethesda, MD 20892, 301–435– 0677, mannl@csr.nih.gov. Name of Committee: Bioengineering Sciences & Technologies Integrated Review Group; Modeling and Analysis of Biological Systems Study Section. Date: February 8–9, 2017. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: The Westin St. Francis, 335 Powell Street, San Francisco, CA 94102. Contact Person: Craig Giroux, Ph.D., Scientific Review Officer, BST IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5150, Bethesda, MD 20892, 301–435–2204, girouxcn@csr.nih.gov. Name of Committee: Endocrinology, Metabolism, Nutrition and Reproductive Sciences Integrated Review Group; Molecular and Cellular Endocrinology Study Section. Date: February 8–9, 2017. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes Street, Arlington, VA 22202. Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review Officer, EMNR IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6182 MSC 7892, Bethesda, MD 20892, 301 435– 2514, riverase@csr.nih.gov. Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group; Synthetic and Biological Chemistry B Study Section. Date: February 8–9, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: New Orleans Marriott Downtown, 859 Convention Center Blvd., New Orleans, LA 70130. Contact Person: Michael Eissenstat, Ph.D., Scientific Review Officer, BCMB IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4166, MSC 7806, Bethesda, MD 20892, 301–435– 1722, eissenstatma@csr.nih.gov. Name of Committee: Surgical Sciences, Biomedical Imaging and Bioengineering Integrated Review Group; Biomedical Imaging Technology A Study Section. Date: February 8–9, 2017. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. VerDate Sep<11>2014 19:05 Jan 10, 2017 Jkt 241001 Contact Person: Ruth Grossman, DDS., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5215, Bethesda, MD 20892, (301) 435–2409, grossmanrs@mail.nih.gov. Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group; Macromolecular Structure and Function D Study Section. Date: February 8, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Washington Plaza Hotel, 10 Thomas Circle NW., Washington, DC 20005. Contact Person: James W Mack, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4154, MSC 7806, Bethesda, MD 20892, (301) 435– 2037, mackj2@csr.nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Genomics, Computational Biology and Technology Study Section. Date: February 8–9, 2017. Time: 11:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Baishali Maskeri, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301–827–2864, maskerib@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: January 5, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–00296 Filed 1–10–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given for the meeting of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention National Advisory Council (CSAP NAC) on February 1, 2017. The Council was established to advise the Secretary, Department of Health and Human Services (HHS); the Administrator, SAMHSA; and Center PO 00000 Frm 00068 Fmt 4703 Sfmt 9990 3347 Director, CSAP concerning matters relating to the activities carried out by and through the Center and the policies respecting such activities. The meeting will be open to the public and will include the discussion of the substance use prevention workforce and the changing landscape of prevention. The meeting will also include updates on CSAP program developments. The meeting will be held in Rockville, Maryland. Attendance by the public will be limited to the space available. Interested persons may present data, information, or views, orally or in writing, on issues pending before the Council. Written submissions should be forwarded to the contact person on or before one week prior to the meeting. Oral presentations from the public will be scheduled at the conclusion of the meeting. Individuals interested in making oral presentations are encouraged to notify the contact on or before one week prior to the meeting. Five minutes maximum will be allotted for each presentation. To attend onsite, submit written or brief oral comments, or request special accommodations for persons with disabilities, please register at the SAMHSA Committees’ Web site, http:// nac.samhsa.gov/Registration/ meetingsRegistration.aspx, or communicate with the CSAP Council’s Designated Federal Officer (see contact information below). Substantive program information may be obtained after the meeting by accessing the SAMHSA Committee Web site, http://nac.samhsa.gov/, or by contacting the Designated Federal Officer. Committee Name: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention National Advisory Council. Date/Time/Type: February 1, 2017, from 9:30 a.m. to 4:30 p.m. EST: (OPEN). Place: SAMHSA, 5600 Fishers Lane, Room 5A02 (lobby level), Rockville, MD 20857, Adobe Connect webcast: https:// samhsa-csap.adobeconnect.com/nac/. Contact: Matthew J. Aumen, Designated Federal Officer, SAMHSA CSAP NAC, 5600 Fishers Lane, Rockville, MD 20857, Telephone: 240– 276–2440, Fax: 301–480–8480, Email: matthew.aumen@samhsa.hhs.gov. Carlos Castillo, Committee Management Officer, SAMHSA. [FR Doc. 2017–00396 Filed 1–10–17; 8:45 am] BILLING CODE 4162–20–P E:\FR\FM\11JAN1.SGM 11JAN1

Agencies

[Federal Register Volume 82, Number 7 (Wednesday, January 11, 2017)]
[Notices]
[Page 3347]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-00396]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given for the 
meeting of the Substance Abuse and Mental Health Services 
Administration's (SAMHSA) Center for Substance Abuse Prevention 
National Advisory Council (CSAP NAC) on February 1, 2017.
    The Council was established to advise the Secretary, Department of 
Health and Human Services (HHS); the Administrator, SAMHSA; and Center 
Director, CSAP concerning matters relating to the activities carried 
out by and through the Center and the policies respecting such 
activities.
    The meeting will be open to the public and will include the 
discussion of the substance use prevention workforce and the changing 
landscape of prevention. The meeting will also include updates on CSAP 
program developments.
    The meeting will be held in Rockville, Maryland. Attendance by the 
public will be limited to the space available. Interested persons may 
present data, information, or views, orally or in writing, on issues 
pending before the Council. Written submissions should be forwarded to 
the contact person on or before one week prior to the meeting. Oral 
presentations from the public will be scheduled at the conclusion of 
the meeting. Individuals interested in making oral presentations are 
encouraged to notify the contact on or before one week prior to the 
meeting. Five minutes maximum will be allotted for each presentation.
    To attend onsite, submit written or brief oral comments, or request 
special accommodations for persons with disabilities, please register 
at the SAMHSA Committees' Web site, http://nac.samhsa.gov/Registration/meetingsRegistration.aspx, or communicate with the CSAP Council's 
Designated Federal Officer (see contact information below).
    Substantive program information may be obtained after the meeting 
by accessing the SAMHSA Committee Web site, http://nac.samhsa.gov/, or 
by contacting the Designated Federal Officer.
    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention National Advisory 
Council.
    Date/Time/Type: February 1, 2017, from 9:30 a.m. to 4:30 p.m. EST: 
(OPEN).
    Place: SAMHSA, 5600 Fishers Lane, Room 5A02 (lobby level), 
Rockville, MD 20857, Adobe Connect webcast: https://samhsa-csap.adobeconnect.com/nac/.
    Contact: Matthew J. Aumen, Designated Federal Officer, SAMHSA CSAP 
NAC, 5600 Fishers Lane, Rockville, MD 20857, Telephone: 240-276-2440, 
Fax: 301-480-8480, Email: matthew.aumen@samhsa.hhs.gov.

Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2017-00396 Filed 1-10-17; 8:45 am]
 BILLING CODE 4162-20-P